FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891966018> ?p ?o ?g. }

• W2891966018 endingPage "379" @default.
• W2891966018 startingPage "370" @default.
• W2891966018 abstract "Despite significantly improved survival and response rates in patients diagnosed with multiple myeloma, it still remains an incurable disease with a poor outcome, especially in high-risk groups. Allogeneic stem cell transplantation offers a potentially curative option but remains controversial due to considerable treatment-related toxicity. We analyzed 109 consecutive myeloma patients who had received reduced-intensity conditioning allogeneic transplantation at the Freiburg University Medical Center between 2000 and 2016. Although most patients were heavily pre-treated in high-risk constellations, the overall response rate was high with 70%, the median overall survival (OS) 39.2%, and the median progression-free survival (PFS) 14.2 months, with a median follow up of 71.5 months. Survival was significantly better in patients with response to previous therapies than in those with progressive disease (median OS 65 vs. 11.5 months, P=0.003; median PFS 18.4 vs. 5.1 months, P=0.001). Moreover, survival of patients transplanted in first-line was significantly prolonged compared to relapsed/refractory disease (median OS not reached vs. 21.6 months, P<0.001; median PFS 47.7 vs. 9.6 months, P<0.001). The non-relapse mortality was relatively low with a cumulative incidence of 12.4% at ten years. Acute graft-versus-host disease (GvHD) grade II-IV was observed in 25%, and moderate or severe chronic GvHD in 24%. Quality of life (QoL) assessed with the revised Myeloma Comorbidity Index before and after transplantation remained unchanged. Our data suggest that allogeneic transplantation in the context of novel immunotherapeutic approaches may enable long-term survival and even a potential cure in a carefully selected subgroup of high-risk multiple myeloma patients with acceptable toxicity and preserved QoL." @default.
• W2891966018 created "2018-09-27" @default.
• W2891966018 creator A5003629209 @default.
• W2891966018 creator A5016360607 @default.
• W2891966018 creator A5023417817 @default.
• W2891966018 creator A5035666187 @default.
• W2891966018 creator A5063647828 @default.
• W2891966018 creator A5074339903 @default.
• W2891966018 creator A5084494517 @default.
• W2891966018 creator A5084803299 @default.
• W2891966018 creator A5085654090 @default.
• W2891966018 creator A5088238455 @default.
• W2891966018 creator A5088789978 @default.
• W2891966018 date "2018-09-20" @default.
• W2891966018 modified "2023-10-17" @default.
• W2891966018 title "Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life" @default.
• W2891966018 cites W121638319 @default.
• W2891966018 cites W1538098067 @default.
• W2891966018 cites W1977390830 @default.
• W2891966018 cites W1982946267 @default.
• W2891966018 cites W1990045245 @default.
• W2891966018 cites W2010766702 @default.
• W2891966018 cites W2020298011 @default.
• W2891966018 cites W2037050131 @default.
• W2891966018 cites W2047840324 @default.
• W2891966018 cites W2049273621 @default.
• W2891966018 cites W2049498583 @default.
• W2891966018 cites W2054567830 @default.
• W2891966018 cites W2060302368 @default.
• W2891966018 cites W2075729465 @default.
• W2891966018 cites W2086735887 @default.
• W2891966018 cites W2095019788 @default.
• W2891966018 cites W2112637662 @default.
• W2891966018 cites W2117648349 @default.
• W2891966018 cites W2122021478 @default.
• W2891966018 cites W2134877860 @default.
• W2891966018 cites W2141451077 @default.
• W2891966018 cites W2144728882 @default.
• W2891966018 cites W2155535356 @default.
• W2891966018 cites W2159773146 @default.
• W2891966018 cites W2161702482 @default.
• W2891966018 cites W2164885965 @default.
• W2891966018 cites W2169288585 @default.
• W2891966018 cites W2171832779 @default.
• W2891966018 cites W2230441773 @default.
• W2891966018 cites W2318069817 @default.
• W2891966018 cites W2397983925 @default.
• W2891966018 cites W2439611081 @default.
• W2891966018 cites W2508231867 @default.
• W2891966018 cites W2566193100 @default.
• W2891966018 cites W2584941439 @default.
• W2891966018 cites W2763322898 @default.
• W2891966018 cites W2763858024 @default.
• W2891966018 cites W2765918174 @default.
• W2891966018 cites W2772946231 @default.
• W2891966018 cites W2785837245 @default.
• W2891966018 cites W2791388253 @default.
• W2891966018 doi "https://doi.org/10.3324/haematol.2018.200881" @default.
• W2891966018 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6355495" @default.
• W2891966018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30237266" @default.
• W2891966018 hasPublicationYear "2018" @default.
• W2891966018 type Work @default.
• W2891966018 sameAs 2891966018 @default.
• W2891966018 citedByCount "50" @default.
• W2891966018 countsByYear W28919660182019 @default.
• W2891966018 countsByYear W28919660182020 @default.
• W2891966018 countsByYear W28919660182021 @default.
• W2891966018 countsByYear W28919660182022 @default.
• W2891966018 countsByYear W28919660182023 @default.
• W2891966018 crossrefType "journal-article" @default.
• W2891966018 hasAuthorship W2891966018A5003629209 @default.
• W2891966018 hasAuthorship W2891966018A5016360607 @default.
• W2891966018 hasAuthorship W2891966018A5023417817 @default.
• W2891966018 hasAuthorship W2891966018A5035666187 @default.
• W2891966018 hasAuthorship W2891966018A5063647828 @default.
• W2891966018 hasAuthorship W2891966018A5074339903 @default.
• W2891966018 hasAuthorship W2891966018A5084494517 @default.
• W2891966018 hasAuthorship W2891966018A5084803299 @default.
• W2891966018 hasAuthorship W2891966018A5085654090 @default.
• W2891966018 hasAuthorship W2891966018A5088238455 @default.
• W2891966018 hasAuthorship W2891966018A5088789978 @default.
• W2891966018 hasBestOaLocation W28919660181 @default.
• W2891966018 hasConcept C126322002 @default.
• W2891966018 hasConcept C141071460 @default.
• W2891966018 hasConcept C151730666 @default.
• W2891966018 hasConcept C2776364478 @default.
• W2891966018 hasConcept C2777408962 @default.
• W2891966018 hasConcept C2779343474 @default.
• W2891966018 hasConcept C2779972918 @default.
• W2891966018 hasConcept C2911091166 @default.
• W2891966018 hasConcept C71924100 @default.
• W2891966018 hasConcept C86803240 @default.
• W2891966018 hasConcept C88879693 @default.
• W2891966018 hasConcept C90924648 @default.
• W2891966018 hasConceptScore W2891966018C126322002 @default.
• W2891966018 hasConceptScore W2891966018C141071460 @default.
• W2891966018 hasConceptScore W2891966018C151730666 @default.
• W2891966018 hasConceptScore W2891966018C2776364478 @default.

• next